Tuesday, May 3, 2022 1:00 pm -2:00 pm Eastern
This interactive live webinar is part 10 of the Emerging and Evolving Biomarkers Series.
Description:
Patterns of somatic mutation, identified through the broad sequencing of human cancers, reflect diverse mechanisms of tumorigenesis. These patterns, so-called mutational signatures, represent emerging biomarkers that provide insight into disease etiology and may impact clinical management. This webinar reviews the mechanistic basis of mutational signatures, the detection of signatures in the molecular laboratory, and potential implications in cancer diagnosis and treatment.
Learning Objectives:
- Describe how mechanisms of mutagenesis lead to distinct mutational signatures.
- Infer common mutational signatures from sequencing data.
- Use mutational signatures to support pathological diagnosis and laboratory quality control.
- Explain how mutational signatures may aid cancer therapy selection.
 |
 |
|---|---|
|
Speaker:
Fei Dong, MD |
Moderator:
Kurtis Davies, MD |
Duration: 1 Hour
This program has been supported through educational grant funding provided by Amgen and Loxo Oncology at Lilly (for further information concerning Lilly grant funding visit www.lillygrantoffice.com.) Supporting companies had no control over its content. No personally-identifiable information regarding you is provided to any grant supporters.
- Click the "Register Now" Button
- Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account.
- Complete the "Demographic questionnaire for Emerging and Evolving Biomarkers Series" before the webinar date. You will only need to do this once for the entire series.
Continuing Education Credit Information
CME credit: 1.0CMLE credit: 1.0
Last day to claim credit: June 4, 2022
Accreditation Statements
AMA PRA Category 1 Credit(s)™
This
activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for Continuing
Medical Education through the joint providership of American Society
for Clinical Pathology (ASCP) and Association for Molecular Pathology
(AMP). The American Society for Clinical Pathology (ASCP) is accredited
by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the
ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements
for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.
